On Wednesday, Egypt's Prime Minister Moustafa Madbouly announced that the country will receive a total of 4.9 million coronavirus vaccine doses this month, amid a surge in coronavirus cases.
In a televised speech, Madbouly added that 1.7 million coronavirus doses will arrive in Egypt in the coming week and 1.7 million doses will arrive by the end of May through the COVID-19 Vaccines Global Access (COVAX).
Also, one million doses of the Chinese Sinopharm vaccine are set to arrive this month in addition to 500,000 doses of the Chinese Sinovac through this week.
As Egypt is preparing to locally produce the Sinovac vaccine, Madbouly said Egypt will soon receive 1,400 liters of the raw material needed to manufacture 2 million vaccine doses.
In April, Egypt’s drug authority said it had approved Chinese biopharmaceutical company Sinovac’s coronavirus vaccine for emergency use.
Over the past few months, Egypt has reiterated its plans to locally produce the Sinovac vaccine to cover local and African needs.
Egypt’s Holding Company for Biological Products and Vaccines (VACSERA) and Sinovac last month signed two agreements to manufacture the vaccine.
VACSERA will manufacture the final product using the ready-made product provided by Sinovac.
The first agreement is related to the transfer of technology required to manufacture the vaccine doses, a Cabinet statement read. Under the agreement, Sinovac will grant VACSERA a limited license to use the manufacturing technology.
VACSERA will manufacture the vaccine inside the company’s production facilities.
The second agreement stipulates that Sinovac secures for Egypt all technical information related to the company’s vaccine and provides technical assistance.
Egypt has started its vaccination campaign in January and is working on expanding vaccination, especially as the country is currently suffering from a third coronavirus wave.
Follow the latest news on Google News
